Eisai
4523.T
#2215
Rank
S$10.96 B
Marketcap
S$38.85
Share price
0.27%
Change (1 day)
5.02%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. an increase over its 2024 EPS that were of S$1.26.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.875.52%
2022S$1.77-74.01%
2021S$6.81-66.58%
2020S$20.3698.24%
2019S$10.2717.01%
2018S$8.7837.78%
2017S$6.37-27.62%
2016S$8.8035.33%
2015S$6.50-2.82%
2014S$6.69-27.66%
2013S$9.25-27.49%
2012S$12.76-12.67%
2011S$14.6188.08%
2010S$7.77-11.06%
2009S$8.74-390.15%
2008S-$3.01-127.78%
2007S$10.8411.78%
2006S$9.704.38%
2005S$9.297.4%
2004S$8.6543.03%
2003S$6.0525.09%
2002S$4.8452.67%
2001S$3.1769.76%
2000S$1.87